Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-24-009384

Options or other derivatives

  • General Counsel/Secretary acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Samuel George A. III General Counsel/Secretary 2024-03-07 Grant or award · Employee Stock Option (Right to Buy) +650,000 650,000 D
Loading xslF345X05/ownership.xml…